Avalo Therapeutics (AVTX) Debt Ratio (2016 - 2025)
Historic Debt Ratio for Avalo Therapeutics (AVTX) over the last 11 years, with Q2 2025 value amounting to 0.0.
- Avalo Therapeutics' Debt Ratio changed N/A to 0.0 in Q2 2025 from the same period last year, while for Jun 2025 it was 0.0, marking a year-over-year change of. This contributed to the annual value of 0.0 for FY2024, which is N/A changed from last year.
- As of Q2 2025, Avalo Therapeutics' Debt Ratio stood at 0.0.
- In the past 5 years, Avalo Therapeutics' Debt Ratio registered a high of 0.58 during Q2 2022, and its lowest value of 0.0 during Q4 2024.
- In the last 5 years, Avalo Therapeutics' Debt Ratio had a median value of 0.35 in 2022 and averaged 0.27.
- Over the last 5 years, Avalo Therapeutics' Debt Ratio had its largest YoY gain of 125.72% in 2022, and its largest YoY loss of 125.72% in 2022.
- Avalo Therapeutics' Debt Ratio (Quarter) stood at 0.41 in 2021, then dropped by 1.26% to 0.4 in 2022, then fell by 28.51% to 0.29 in 2023, then crashed by 99.17% to 0.0 in 2024, then grew by 22.39% to 0.0 in 2025.
- Its Debt Ratio was 0.0 in Q2 2025, compared to 0.0 in Q1 2025 and 0.0 in Q4 2024.